DrugCite
Search

EXTAVIA

Adverse Events
Drug Profile
Learn More
Reference
About Results
Comments

Extavia Adverse Events Reported to the FDA Over Time

How are Extavia adverse event reports trending over time?

This graph shows volume of adverse events submitted to the FDA by quarter for Extavia, as well as related generic and/or brandname drugs containing the same primary active ingredients. Adverse events are counted if Extavia is flagged as the suspect drug causing the adverse event.

Most Common Extavia Adverse Events Reported to the FDA

What are the most common Extavia adverse events reported to the FDA?

Injection Site Erythema
529 (3.05%)
Fatigue
528 (3.04%)
Multiple Sclerosis Relapse
496 (2.86%)
Headache
421 (2.42%)
Injection Site Pain
383 (2.2%)
Influenza Like Illness
373 (2.15%)
Pain
337 (1.94%)
Chills
299 (1.72%)
Hypoaesthesia
296 (1.7%)
Pyrexia
295 (1.7%)
Gait Disturbance
289 (1.66%)
Show More Show More
Injection Site Haematoma
289 (1.66%)
Depression
263 (1.51%)
Feeling Abnormal
245 (1.41%)
Nausea
236 (1.36%)
Dizziness
215 (1.24%)
Asthenia
212 (1.22%)
Pain In Extremity
193 (1.11%)
Malaise
186 (1.07%)
Muscular Weakness
186 (1.07%)
Fall
181 (1.04%)
Muscle Spasms
179 (1.03%)
Paraesthesia
171 (.98%)
Injection Site Swelling
170 (.98%)
Insomnia
163 (.94%)
Dyspnoea
143 (.82%)
Balance Disorder
138 (.79%)
Hyperhidrosis
133 (.77%)
Injection Site Reaction
133 (.77%)
Vision Blurred
133 (.77%)
Injection Site Pruritus
128 (.74%)
Stress
127 (.73%)
Back Pain
122 (.7%)
Myalgia
109 (.63%)
Migraine
101 (.58%)
Vomiting
94 (.54%)
Arthralgia
93 (.54%)
Injection Site Discolouration
91 (.52%)
Abdominal Discomfort
90 (.52%)
Injection Site Mass
89 (.51%)
Weight Increased
89 (.51%)
Diarrhoea
88 (.51%)
Nasopharyngitis
86 (.5%)
Abdominal Pain
84 (.48%)
Tremor
80 (.46%)
Drug Ineffective
79 (.45%)
Weight Decreased
79 (.45%)
Memory Impairment
75 (.43%)
Influenza
73 (.42%)
Feeling Hot
71 (.41%)
Depressed Mood
70 (.4%)
Anxiety
67 (.39%)
Contusion
67 (.39%)
Decreased Appetite
67 (.39%)
Musculoskeletal Stiffness
67 (.39%)
Oedema Peripheral
67 (.39%)
Burning Sensation
65 (.37%)
Limb Discomfort
64 (.37%)
Hypokinesia
62 (.36%)
Somnolence
62 (.36%)
Irritability
61 (.35%)
Pruritus
60 (.35%)
Abdominal Pain Upper
57 (.33%)
Speech Disorder
57 (.33%)
Urinary Tract Infection
57 (.33%)
Erythema
56 (.32%)
Visual Impairment
56 (.32%)
Sleep Disorder
55 (.32%)
Chest Pain
54 (.31%)
Urticaria
53 (.31%)
Optic Neuritis
52 (.3%)
Panic Attack
52 (.3%)
Urinary Incontinence
52 (.3%)
Pneumonia
50 (.29%)
Neck Pain
48 (.28%)
Crying
47 (.27%)
Constipation
46 (.26%)
Bronchitis
45 (.26%)
Cystitis
45 (.26%)
Temperature Intolerance
42 (.24%)
Central Nervous System Lesion
41 (.24%)
Chest Discomfort
41 (.24%)
Injection Site Haemorrhage
41 (.24%)
Movement Disorder
41 (.24%)
Multiple Sclerosis
41 (.24%)
Rhinorrhoea
41 (.24%)
Sensation Of Heaviness
40 (.23%)
Hot Flush
39 (.22%)
Muscle Spasticity
39 (.22%)
Vertigo
39 (.22%)
Cognitive Disorder
38 (.22%)
Cough
38 (.22%)
Convulsion
37 (.21%)
Loss Of Consciousness
37 (.21%)
Abasia
36 (.21%)
Aspartate Aminotransferase Increase...
34 (.2%)
Eye Pain
34 (.2%)
Liver Function Test Abnormal
34 (.2%)
Sinusitis
34 (.2%)
Feeling Cold
33 (.19%)
Injection Site Urticaria
33 (.19%)

ExportShare/Embed GraphExport Export Data

This graph shows the top adverse events submitted to the FDA for Extavia, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Extavia is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.

Adverse Event Categories for Extavia

What are the most common Extavia adverse events reported to the FDA?

Show More Show More

ExportShare/Embed Graph Export Export Data

This graph shows the top categories of adverse events submitted to the FDA for Extavia, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Extavia is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.

Common Uses of Extavia According to Those Reporting Adverse Events

Why are people taking Extavia, according to those reporting adverse events to the FDA?

Multiple Sclerosis
1632
Relapsing-remitting Multiple Sclero...
77
Multiple Sclerosis Relapse
6
Secondary Progressive Multiple Scle...
5
Product Used For Unknown Indication
3
Clinically Isolated Syndrome
3
Show More Show More
Muscle Spasticity
2
Drug Use For Unknown Indication
1
Progressive Multiple Sclerosis
1
Primary Progressive Multiple Sclero...
1
Myelitis
1
Myocarditis
1
Encephalomyelitis
1

Drug Labels

LabelLabelerEffective
ExtaviaNovartis Pharmaceuticals Corporation25-MAR-12

Extavia Case Reports

What Extavia safety concerns are being reported by doctors and researchers in the medical literature?

Powered by Google

About Results

This report contains aggregated drug side effects and adverse events for Extavia. The data has been pulled from the United States Food and Drug Administration's (US FDA) Adverse Event Reporting System (AERS), a database containing more than 4,000,000 adverse event reports.

DrugCite expands your query using the Unified Medical Language System (UMLS) to include generic drugs and primary active ingredients. While the core of DrugCite's advanced drug filtering algorithm is based on the industry standard UMLS, DrugCite's proprietary filtering system also includes dozens of additional steps to reconcile malformed drug names in the FDA's data.

DrugCite only counts a drug if the submitter of the adverse event indicates that the drug is suspected to have caused the adverse event.

Depending on how the data is aggregated, different counts may occur. When someone submits an adverse event to the FDA, the submitter can attribute multiple adverse events to one or more drugs. For example, an individual taking Paxil could submit the adverse events "anxiety" and "suicidal ideation" for the same individual safety report (ISR). This means when DrugCite aggregates by adverse event, two distinct adverse events are counted in the adverse event graph; once for "anxiety" and again for "suicidal ideation". However, when DrugCite aggregates by individual safety reports irrespective of the details of the adverse events contained within the safety report, the report is only counted once.

Comments

Share your experience with Extavia.